Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update.

Recommendations for the detection and diagnosis of Niemann-Pick disease type C: An update.
复制标题

DOI:
10.1212/cpj.0000000000000399
复制
发表时间:
2017-12
期刊:
Neurology. Clinical practice
影响因子:
--
通讯作者:
Marquardt T
Marquardt T
中科院分区:
其他
文献类型:
--
作者:
Patterson MC;Clayton P;Gissen P;Anheim M;Bauer P;Bonnot O;Dardis A;Dionisi-Vici C;Klünemann HH;Latour P;Lourenço CM;Ory DS;Parker A;Pocoví M;Strupp M;Vanier MT;Walterfang M;Marquardt T

文献摘要

被引文献

相似文献

尼曼-匹克病C型(NP-C)是一种神经内脏疾病,可能比早期估计的更为普遍。NP-C的诊断常常被延迟;临床实践的一个关键目标是减少这种延迟。最近,在NP-C筛查和诊断领域取得了重大进展,有理由对现有的临床实践建议进行更新。新的生物标志物分析和遗传分析技术被列入NP-C的一线诊断测试。现在大多数诊断都可以通过生物标志物和基因分析的结合来证实。Filipin染色对不确定的病例可能有助于诊断。建议提供给精神科医生,神经眼科医生和放射科医生,并筛选特定的高危患者队列。对NP-C诊断算法进行了更新和简化。本出版物为临床医生提供了专家建议,这些临床医生可能会看到出现NP-C症状和体征的患者,包括全科医生、儿科医生、神经科医生和精神科医生。
Niemann-Pick disease type C (NP-C) is a neurovisceral disorder that may be more prevalent than earlier estimates. Diagnosis of NP-C is often delayed; a key aim for clinical practice is to reduce this delay. Recently, substantial progress has been made in the field of NP-C screening and diagnosis, justifying an update to the existing recommendations for clinical practice. New biomarker profiling and genetic analysis technologies are included as first-line diagnostic tests for NP-C. Most diagnoses can now be confirmed by combination of biomarker and genetic analyses. Filipin staining may facilitate diagnosis in uncertain cases. Recommendations are provided for psychiatrists, neuro-ophthalmologists, and radiologists, and on screening within specific at-risk patient cohorts. The NP-C diagnostic algorithm has been updated and simplified. This publication provides expert recommendations for clinicians who may see patients presenting with the signs and symptoms of NP-C, including general practitioners, pediatricians, neurologists, and psychiatrists.